Autism Spectrum Disorder Trial, Recruiting NCT04532424 Sponsor: Stanford University Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT04532424
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Autism Spectrum Disorder (ASD)
  • Your ASD diagnosis has been confirmed through recognised clinical assessment tools
  • You are between 12 and 45 years old
  • You have a trusted person in your life (such as a family member or caregiver) who can fill out questionnaires about you
  • You score highly (50% or above) on a specific assessment measuring repetitive or rigid behaviours, such as a strong need for sameness, obsessive or compulsive behaviours, or unusual intense interests

Who may not be able to join:

  • You have a history of seizures or epilepsy, unless they were caused by substances or fever with supporting medical evidence and no seizures in the past 12 months (confirm with trial site)
  • You are pregnant
  • You have a physical health condition that the study doctor feels could put you at risk or affect the study results (confirm with trial site)
  • You have used cocaine, amphetamines, or benzodiazepines within the past week, or a drug test shows these in your system
  • You are currently experiencing withdrawal symptoms from alcohol or benzodiazepines
  • You have a diagnosis of bipolar disorder or a psychotic disorder such as schizophrenia
  • You have a significant vision or hearing impairment, such as blindness or deafness
  • You are currently experiencing severe sleep problems — you must be able to sleep at least 4 hours the night before each treatment session
  • You are not willing to cooperate with the brain stimulation procedures used in this trial
  • You are currently taking Clozapine or another medication that the lead researcher believes could make the brain stimulation unsafe or less effective (confirm with trial site)
  • The level of brain stimulation needed for treatment cannot be delivered safely or comfortably for you (confirm with trial site)
  • You have health conditions that put you at higher risk from COVID-19, based on university guidelines at the time (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Antonio Y. Hardan, MD, Stanford University

Phone: (650) 736-1235

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 January 2021
Est. completion
1 December 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Repetitive Behavior Scale-Revised (RBS-R)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov